We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MYOR:IDXPT Mayora Indah Tbk Analysis

Data as of 2026-03-12 - not real-time

IDR 1,855.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Mayora shares are trading close to a key support level with the RSI sitting in the low‑30s, suggesting oversold conditions, while the MACD histogram remains negative, indicating bearish momentum. The stock’s beta below one points to lower systematic risk, yet a 30‑day volatility above 40% signals pronounced price swings. The consumer defensive sector provides a cushion against economic cycles, and a dividend yield near 3% with a payout ratio under 50% underscores cash‑flow strength. Technical pressure is evident, but fundamental metrics such as a modest PE around 14‑times earnings and a forward PE under 12‑times suggest reasonable valuation relative to peers. Recent analyst commentary highlights seasonal demand spikes around the Lunar New Year and a recovery in consumer purchasing power, which could catalyze a short‑term bounce.
Looking ahead, the discounted cash‑flow model indicates upside potential of roughly 50%, and forward EPS estimates point to double‑digit earnings growth in 2026. The company’s solid ROE above 15% and free cash flow generation support a sustainable dividend and potential reinvestment. Consensus analyst sentiment is bullish with a “buy” rating, reinforcing the case for positioning now. Combined, the technical floor, defensive positioning, and upside valuation make Mayora a compelling candidate for investors seeking a blend of income and growth.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold technical indicators (low RSI, negative MACD)
  • Support level near current price
  • Seasonal demand lift from upcoming festivals

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF‑derived upside of ~50%
  • Improving earnings outlook and forward EPS growth
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong brand portfolio in a defensive consumer segment
  • Consistent cash‑flow generation supporting dividends and reinvestment
  • Analyst consensus buy rating and positive earnings momentum

Key Metrics & Analysis

Financial Health

Revenue Growth-0.60%
Profit Margin7.54%
P/E Ratio14.6
ROE17.17%
ROA7.31%
Debt/Equity51.34
P/B Ratio2.4
Op. Cash FlowIDR2397.8B
Free Cash FlowIDR1141.7B

Technical Analysis

TrendNeutral
RSI31.1
SupportIDR 1,835.00
ResistanceIDR 2,380.00
MA 20IDR 2,098.25
MA 50IDR 2,166.10
MA 200IDR 2,145.10
MACDBearish
VolumeStable
Fear & Greed Index76.84

Valuation

Fair ValueIDR 504.48
Target PriceIDR 2,793.33
Upside/Downside50.58%
GradeUndervalued
TypeBlend
Dividend Yield2.94%

Risk Assessment

Beta0.64
Volatility45.34%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.